Castle Biosciences, Inc. (CSTL)
NASDAQ · Healthcare
Castle Biosciences, Inc. Revenue 2018–2025
Castle Biosciences, Inc. annual/quarterly revenue history and growth rate from 2018 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Castle Biosciences, Inc. revenue for the quarter ending March 31, 2026 was 83.7 M, a 4.90% decrease year-over-year.
- Castle Biosciences, Inc. revenue for the twelve months ending March 31, 2026 was 340.9 M, a 10.95% increase year-over-year.
- Castle Biosciences, Inc. annual revenue for 2025 was 344.2 M, a 3.66% increase from 2024.
- Castle Biosciences, Inc. annual revenue for 2024 was 332.1 M, a 51.09% increase from 2023.
- Castle Biosciences, Inc. annual revenue for 2023 was 219.8 M, a 60.38% increase from 2022.
- Castle Biosciences, Inc. annual revenue for 2022 was 137.0 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Castle Biosciences, Inc. Revenue — FAQ
Castle Biosciences, Inc. (CSTL) revenue over the last 8 years — annual and quarterly figures with year-over-year growth and charts.
What is Castle Biosciences, Inc.'s revenue?
Castle Biosciences, Inc. (CSTL) reported revenue of $344M for fiscal 2025.
Where can I see CSTL's revenue history?
The chart and table above show Castle Biosciences, Inc.'s revenue by year and by quarter, including the growth rate.